Long‐term outcomes of patients with limited‐stage ocular adnexal DLBCL treated with combined modality therapy in the rituximab era
暂无分享,去创建一个
A. Zelenetz | A. Dogan | H. Schöder | B. Imber | P. Hamlin | M. Matasar | J. Yahalom | Anita Kumar | A. Noy | M. Okwali | L. Falchi | O. Lahoud | C. Owens | G. Salles | Victoria S. North | D. Qualls